ASCENT procurement announcement: Requests for quotation

Monday 13 January

The ASCENT project has two requests for quotation (RFQ’s): 1. For printing of cardstock medication sleeves. 2. To facilitate incoming and outgoing interactions with adherence platform. KNCV Tuberculosis Foundation KNCV […]

Resistant forms of TB: more patient-friendly treatment

Monday 13 January

People suffering from resistant forms of tuberculosis (TB) can now be cured by more patient-friendly treatments. The World Health Organization (WHO) recommends the use of these new treatments under certain […]

TB Stigma Reduction Symposium

Sunday 12 January

INVITATION: Stigma and discrimination are recognized as some of the most commonly identified barriers to fight the Tuberculosis (TB) epidemic. During the TB Stigma Reduction Symposium: “You have to know […]

The story of Abdurahim

Sunday 12 January

Four-year-old Abdurahim from Kyrgyzstan is so small he looks half that age. He had spinal and intra-thoracic lymph node tuberculosis (TB), a very rare and dangerous form of the disease […]

Start of a new era in fight against drug resistant TB

Thursday 12 December

WHO released a rapid communication on the treatment of drug resistant (DR) and extensively drug resistant (XDR) tuberculosis (TB). This puts an ‘end to tears’, for painful daily injections in […]

7th European Advanced Course in Clinical Tuberculosis

Wednesday 20 November

The 7th European Advanced Course in Clinical Tuberculosis (TB) offered an informative and interactive program with national and international speakers with a comprehensive experience in the field of clinical tuberculosis […]

3HP regimen soon to be accessible in Malawi

Thursday 31 October

KNCV Tuberculosis Foundation Malawi welcomes the substantial reduction in the price of the anti-tuberculosis drug rifapentine, announced today at the Union World Conference on Lung Health in India. “For people […]

Important price reduction improves access to TB prevention

Thursday 31 October

KNCV Tuberculosis Foundation welcomes the announcement of a substantial reduction in the price of an anti-tuberculosis medicine through the support of Unitaid and the Global Fund, in partnership with the […]

Innovative TB treatment support project kicks off in the Philippines

Wednesday 25 September

ASCENT aims to assist patients succeed in treatment using digital adherence technology. On World Lung Day, the innovative TB treatment support project ASCENT kicks off in the Philippines, making the […]

Antacid helps tuberculosis bacteria to survive

Sunday 1 September

In 2017, some 10 million people suffered from tuberculosis and 1.6 million died of the disease. One reason why infection with Mycobacterium tuberculosis is so difficult to treat is that […]

FDA approval of BPaL regimen an important breakthrough in TB control

Wednesday 14 August

The US Food & Drug Administration (FDA) today approved pretomanid for the treatment of highly drug-resistant forms of tuberculosis (TB) in a combination regimen known as BPaL. This regimen was […]

ASCENT: Empowering patients through digital technology

Tuesday 23 July

GENEVA/THE HAGUE, The next three and a half years, KNCV Tuberculosis Foundation will lead the innovative ASCENT project, which stands for Adherence Support Coalition to End TB. This brand new […]